反応式
Cl.C(N=C=NCCCN(C)C)C.CN(C1C=CC=CN=1)C.[Cl:22][C:23]1[CH:31]=[CH:30][C:26]([C:27](O)=[O:28])=[C:25]([NH:32][C@H:33]2[CH2:38][CH2:37][CH2:36][CH2:35][C@@H:34]2[N:39]2[CH2:43][CH2:42][CH2:41][CH2:40]2)[CH:24]=1.[NH2:44][C:45]1[CH:54]=[C:53]2[C:48]([CH2:49][CH2:50][C:51](=[O:56])[N:52]2[CH3:55])=[CH:47][CH:46]=1>C(Cl)Cl>[Cl:22][C:23]1[CH:31]=[CH:30][C:26]([C:27]([NH:44][C:45]2[CH:54]=[C:53]3[C:48]([CH2:49][CH2:50][C:51](=[O:56])[N:52]3[CH3:55])=[CH:47][CH:46]=2)=[O:28])=[C:25]([NH:32][C@H:33]2[CH2:38][CH2:37][CH2:36][CH2:35][C@@H:34]2[N:39]2[CH2:40][CH2:41][CH2:42][CH2:43]2)[CH:24]=1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
Hydrochloride of 1-ethyl-3-[3-(N,N-dimethylamino)propyl]carbodiimide (174 mg) and dimethylaminopyridine (21 mg) were added to a methylene chloride (5 mL) solution of 4-chloro-2-{[(1S*,2S*)-2-pyrrolidin-1-ylcyclohexyl]amino}benzoic acid (220 mg) and 7-amino-1-methyl-3,4-dihydroquinolin-2(1H)-one (100 mg). After stirring the reaction liquid overnight at room temperature, the reaction liquid was concentrated under a reduced pressure. By purifying the residue by silica gel column chromatography (hexane:ethyl acetate, 1:0 to 1:1), 4-chloro-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)-2-{[(1S*,2S*)-2-pyrrolidin-1-ylcyclohexyl]amino}benzamide was obtained as a pale yellow amorphous. By treating this with 4 M hydrogen chloride/ethyl acetate solution, 4-chloro-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)-2-{[(1S*,2S*)-2-pyrrolidin-1-ylcyclohexyl]amino}benzamide hydrochloride (212 mg) was obtained as an amorphous.
後処理
- customthe reaction liquid overnight at room temperature
- customthe reaction liquid
- concentrationwas concentrated under a reduced pressure
- customBy purifying the residue by silica gel column chromatography (hexane:ethyl acetate, 1:0 to 1:1)
出典と根拠
- ORDレコード
- ord-90288db1859a476595d3fc0a22c4adbc
- 出典データセット
- uspto-grants-2012_01
- 特許番号
- US08106190B2
関連ノート
読み込み中…